| 000 | 00898nmm a2200325Ia 4500 | ||
|---|---|---|---|
| 008 | 140908s9999 xx 000 0 und d | ||
| 020 | _a9783642295263, 978-3-642-29526-3 | ||
| 040 | _aNISER LIBRARY | ||
| 041 | _aEnglish | ||
| 082 |
_a571.6, _b23 |
||
| 245 | _aIntellectual Property Issues | ||
| 500 | _aBiomedical and Life Sciences (Springer-11642) | ||
| 650 | _aAntibodies | ||
| 650 | _aBiotechnology | ||
| 650 | _aBiotechnology | ||
| 650 | _aCell Biology | ||
| 650 | _aCommercial law | ||
| 650 | _aCommercial Law | ||
| 650 | _aCytology | ||
| 650 | _aLife sciences | ||
| 650 | _aLife Sciences | ||
| 650 | _aMonoclonal antibodies | ||
| 650 | _aPharmaceutical Sciences/Technology | ||
| 650 | _aPharmaceutical technology | ||
| 650 | _aVaccine | ||
| 650 | _aVaccines | ||
| 700 | _aStorz, Ulrich. | ||
| 856 | _uhttp://dx.doi.org/10.1007/978-3-642-29526-3 | ||
| 942 | _cEB | ||
| 999 |
_c18674 _d18674 |
||